Pseudomedicine and Potential Dementia Treatments? (JAMA)

Summary

A United States perspective covers the growing market for complementary interventions to promote brain health or minimise dementia risk and/or symptoms. Health professionals are requested to help the public understand commercial conflicts of interest and the market forces behind the promotion of unproven treatments.

A Due Sense of Context and Uncertainties?

A quick glimpse at the readers’ replies indicates that there is little room for dogmatic one-sidedness in this debate.

Full Text Link

Reference

Hellmuth, J. Rabinovici, GD. [and] Miller, BL. (2019). The rise of pseudomedicine for dementia and brain health. JAMA. January 25th 2019. [Epub ahead of print].

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.